Get the Stockscreener App
34.47
12.66%
-4.995
Scholar Rock Holding Corp stock is traded at $34.47, with a volume of 9.15M.
It is down -12.66% in the last 24 hours and up +8.83% over the past month.
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
See More
Previous Close:
$39.46
Open:
$32.87
24h Volume:
9.15M
Relative Volume:
4.18
Market Cap:
$3.32B
Revenue:
$47.30M
Net Income/Loss:
$-225.97M
P/E Ratio:
-14.67
EPS:
-2.35
Net Cash Flow:
$-188.86M
1W Performance:
-13.40%
1M Performance:
+8.83%
6M Performance:
+23.09%
1Y Performance:
+30.01%
1-Day Range:
$29.00
$35.42
1-Week Range:
$29.00
$43.48
52-Week Range:
$22.71
$46.98
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Name
Scholar Rock Holding Corp
Sector
Industry
Phone
857-259-3860
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
34.53 | 3.79B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.35 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.91 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.57 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
802.59 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.68 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-09-25 | Initiated | BofA Securities | Buy |
| Sep-17-25 | Initiated | Barclays | Overweight |
| Sep-15-25 | Initiated | Leerink Partners | Outperform |
| Aug-21-25 | Resumed | Jefferies | Buy |
| Jul-30-25 | Resumed | Raymond James | Strong Buy |
| Jul-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-26-24 | Reiterated | H.C. Wainwright | Buy |
| Oct-07-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-24 | Initiated | Raymond James | Strong Buy |
| Oct-25-23 | Upgrade | Jefferies | Hold → Buy |
| Apr-03-23 | Resumed | Piper Sandler | Overweight |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Jul-12-22 | Initiated | Truist | Buy |
| Mar-23-22 | Initiated | H.C. Wainwright | Buy |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | Credit Suisse | Outperform |
| Jan-06-21 | Initiated | JP Morgan | Overweight |
| Mar-12-20 | Initiated | Robert W. Baird | Outperform |
View All
Scholar Rock Holding Corp Stock (SRRK) Latest News
Why Is Scholar Rock Stock Trading Lower On Monday? - Benzinga
Scholar Rock (SRRK) Sees Significant Stock Decline - GuruFocus
Scholar Rock (NASDAQ:SRRK) Shares Gap DownWhat's Next? - MarketBeat
Scholar Rock Sees Unusually Large Options Volume (NASDAQ:SRRK) - MarketBeat
Scholar Rock (SRRK) Shares Plummet Amid Market Volatility - GuruFocus
Scholar Rock says FDA determined Catalent Indiana inspection classification as OAI - MarketScreener
Scholar Rock Says FDA Determined Catalent Indiana Inspection Classification As OAI - TradingView
Fastenal Posts Downbeat Earnings, Joins Vince Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Candlestick signals on Scholar Rock Holding Corporation stock todayWeekly Trading Summary & Weekly Return Optimization Plans - newser.com
Multi factor analysis applied to Scholar Rock Holding Corporation - newser.com
Why analysts remain bullish on Scholar Rock Holding Corporation stockTake Profit & Fast Entry High Yield Tips - newser.com
Is Scholar Rock Holding Corporation a good long term investmentGap Fill Strategies & Exceptional Profit Trading - earlytimes.in
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Purchases 455,753 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
Will Analyst Attention on SRRK Spotlight the Strategic Risks in Scholar Rock’s FDA Response Plan? - simplywall.st
Scholar Rock Holding's Srinivas Akkaraju Acquires 3,707% More Stock - Yahoo Finance
Scholar Rock jumps following Regeneron Eylea update - MSN
Bank of America Begins Coverage on Scholar Rock (NASDAQ:SRRK) - MarketBeat
What MACD and RSI say about Scholar Rock Holding CorporationTrade Signal Summary & Expert Approved Momentum Ideas - newser.com
Why Scholar Rock (SRRK) Stock is Gaining Today - GuruFocus
Why Scholar Rock Stock Raced 6% Higher Today - The Motley Fool
BofA Securities initiates coverage on Scholar Rock stock with Buy rating - Investing.com Nigeria
This Oracle Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga
B of A Securities Initiates Coverage on SRRK with a Buy Rating | - GuruFocus
Why Scholar Rock Holding Corporation (2QK) stock stays on top picksJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Scholar Rock (NASDAQ:SRRK) - MarketBeat
Visualizing Scholar Rock Holding Corporation stock with heatmapsJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
US FDA expands use of Regeneron's Libtayo as add-on treatment for skin cancer - Reuters
Insider Stock Purchases: October 08, 2025 - Quiver Quantitative
Scholar Rock Holding Corporation Stock (SRRK) Opinions on Insider Purchase and FDA Delay - Quiver Quantitative
Wednesday’s Insider Activity: Top Buys and Sells from Tuesday Trading By Investing.com - Investing.com Nigeria
Srinivas Akkaraju Acquires 113,025 Shares of Scholar Rock (NASDAQ:SRRK) Stock - MarketBeat
Scholar Rock (NASDAQ:SRRK) Director Purchases $14,438,919.78 in Stock - MarketBeat
Scholar Rock (SRRK) director Akkaraju buys shares worth $18.8 million - Investing.com
A Fresh Look at Scholar Rock (SRRK) Valuation Following FDA Setback for Apitegromab Approval - simplywall.st
Scholar Rock (SRRK): Assessing Valuation Following FDA Setback for Apitegromab Approval - Yahoo Finance
How strong is Scholar Rock Holding Corporation (2QK) stock earnings growth2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com
Here's How Much You Would Have Made Owning Scholar Rock Holding Stock In The Last 5 Years - Sahm
Historical volatility pattern of Scholar Rock Holding Corporation visualizedMarket Risk Report & Reliable Volume Spike Alerts - newser.com
Will Scholar Rock Holding Corporation (2QK) stock recover faster than industryWeekly Trade Review & High Conviction Buy Zone Alerts - newser.com
Published on: 2025-10-05 01:03:01 - newser.com
Will Scholar Rock Holding Corporation (2QK) stock sustain uptrend momentum - newser.com
Scholar Rock Surges 405% in 2024 Is There Still Upside After Recent Pipeline Progress? - simplywall.st
Published on: 2025-10-03 06:20:05 - newser.com
How Investors May Respond To Scholar Rock Holding (SRRK) FDA Delay Tied to Manufacturing Partner Issues - simplywall.st
Why millennials buy Scholar Rock Holding Corporation (2QK) stockJuly 2025 Sector Moves & Fast Entry and Exit Trade Plans - newser.com
AMI Asset Management Corp Invests $1.05 Million in Scholar Rock Holding Corporation $SRRK - MarketBeat
Regeneron (REGN) Gets a Buy from Leerink Partners - The Globe and Mail
Scholar Rock (NASDAQ:SRRK) Trading Down 4.3%What's Next? - MarketBeat
What consensus target says about Scholar Rock Holding Corporation (2QK) stockRisk Management & Low Risk High Win Rate Picks - newser.com
Should you wait for a breakout in Scholar Rock Holding Corporation2025 Volume Leaders & Daily Risk Controlled Trade Plans - newser.com
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Scholar Rock Holding Corp Stock (SRRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Scholar Rock Holding Corp Stock (SRRK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director |
Oct 06 '25 |
Buy |
38.65 |
113,025 |
4,368,808 |
500,439 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER |
Sep 22 '25 |
Sale |
30.67 |
3,353 |
102,846 |
108,964 |
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):